欧盟反垄断机构表示，已接受赛诺菲提出的让步条件，以结束针对这家法国制药商流感疫苗营销活动的竞争调查。
The European Union’s antitrust body said it accepted Sanofi’s SAN 0.06%increase; up pointing triangle concessions to end a competition investigation into the French drugmaker’s marketing campaign for a flu vaccine.
作为该欧盟集团的执行机构和竞争执法部门，欧盟委员会于周三表示，赛诺菲承诺纠正其过去关于澳大利亚CSL公司生产的竞争对手流感疫苗的信息所产生的潜在影响，并不再进行任何对其效力产生质疑的宣传，这将解决其担忧。该机构补充说，这些承诺将对赛诺菲具有法律约束力。
The European Commission—the bloc’s executive arm and competition enforcer—said Wednesday that Sanofi’s offer to rectify the potential effects of its past messages on a rival flu shot made by Australia’s CSL and refrain from any communication casting doubt about its performance would address its concerns. Those commitments will become legally binding for Sanofi, it added.